Skip to main content
Journal cover image

Sodium-Glucose Co-Transporter-2 Inhibitor Therapy During Anthracycline Treatment: Is There a Role for Cardioprotection?

Publication ,  Journal Article
Khouri, MG; Greene, SJ
Published in: JACC Heart Fail
August 2022

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

JACC Heart Fail

DOI

EISSN

2213-1787

Publication Date

August 2022

Volume

10

Issue

8

Start / End Page

568 / 570

Location

United States

Related Subject Headings

  • Symporters
  • Sodium-Glucose Transporter 2 Inhibitors
  • Sodium
  • Humans
  • Heart Failure
  • Glucose
  • Anthracyclines
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Khouri, M. G., & Greene, S. J. (2022). Sodium-Glucose Co-Transporter-2 Inhibitor Therapy During Anthracycline Treatment: Is There a Role for Cardioprotection? JACC Heart Fail, 10(8), 568–570. https://doi.org/10.1016/j.jchf.2022.04.014
Khouri, Michel G., and Stephen J. Greene. “Sodium-Glucose Co-Transporter-2 Inhibitor Therapy During Anthracycline Treatment: Is There a Role for Cardioprotection?JACC Heart Fail 10, no. 8 (August 2022): 568–70. https://doi.org/10.1016/j.jchf.2022.04.014.
Khouri, Michel G., and Stephen J. Greene. “Sodium-Glucose Co-Transporter-2 Inhibitor Therapy During Anthracycline Treatment: Is There a Role for Cardioprotection?JACC Heart Fail, vol. 10, no. 8, Aug. 2022, pp. 568–70. Pubmed, doi:10.1016/j.jchf.2022.04.014.
Journal cover image

Published In

JACC Heart Fail

DOI

EISSN

2213-1787

Publication Date

August 2022

Volume

10

Issue

8

Start / End Page

568 / 570

Location

United States

Related Subject Headings

  • Symporters
  • Sodium-Glucose Transporter 2 Inhibitors
  • Sodium
  • Humans
  • Heart Failure
  • Glucose
  • Anthracyclines
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology